Assessing SleeP IN Infants With Atopic Dermatitis by Longitudinal Evaluation
NCT05031754 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2022-05-27
Summary
The SPINDLE study will examine sleep in infants with atopic dermatitis by serial assessment over the first year of life, in comparison to infants without atopic dermatitis. Sleep will be assessed using electroencephalography, actigraphy, and sleep questionnaires.
Conditions
- Atopic Dermatitis
- Sleep Disturbance
Sponsors & Collaborators
-
Wellcome Trust
collaborator OTHER -
Health Service Executive, Ireland
collaborator OTHER -
Health Research Board, Ireland
collaborator OTHER -
University College Cork
lead OTHER
Principal Investigators
-
Geraldine Boylan, PhD · INFANT, University College Cork
Eligibility
- Min Age
- 6 Months
- Max Age
- 18 Months
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-12-03
- Primary Completion
- 2023-07-31
- Completion
- 2023-07-31
Countries
- Ireland
Study Locations
More Related Trials
-
Clinical Relevance of Scratching and Sleep in Atopic Dermatitis
NCT05467046 ·Status: COMPLETED
-
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
NCT02975206 ·Status: COMPLETED ·Phase: PHASE2
-
Wearable Skin Sensors to Assess Nocturnal Scratch Behavior
NCT03770858 ·Status: COMPLETED
-
Clinical vs. Anecdotal Evidence - Pediatric Atopic Dermatitis
NCT03559075 ·Status: COMPLETED
-
Sleep & Quality of Life Evaluation of Patients With Atopic Dermatitis Based on E-diary on a Smartphone Application and Actigraphy
NCT03090178 ·Status: COMPLETED ·Phase: NA
-
Scratch and Sleep Quantification in Atopic Dermatitis
NCT03490877 ·Status: COMPLETED
-
Effectiveness of a Combined Dermatological Treatment in Children With Atopic Dermatitis
NCT02920411 ·Status: COMPLETED ·Phase: NA
-
Stress-induced Scratching in Healthy and AD
NCT04174651 ·Status: COMPLETED ·Phase: NA
-
Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic Dermatitis
NCT00351052 ·Status: COMPLETED ·Phase: PHASE3
-
Retention of Vernix Caseosa in Newborns for Primary Prevention of Atopic Dermatitis
NCT07333378 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effectiveness of Melatonin for Sleep Disturbances in Children With Atopic Dermatitis
NCT01638234 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Observational Evaluation of Atopic Dermatitis in Pediatric Patients
NCT03687359 ·Status: ACTIVE_NOT_RECRUITING
-
Asthma and Atopic Dermatitis Validation of PROMIS Pediatric Instruments
NCT03051347 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Reliability/Feasibility of Using Emerald Touchless Sensor for Scratching and Sleep Quantification in a Subset of Participants From PEDISTAD Study (OBS15333; NCT03687359)
NCT05235724 ·Status: COMPLETED
-
Molecular and Cellular Characterization of Spongiotic Dermatitis
NCT00371163 ·Status: COMPLETED
-
Verification Study of Ciclosporin for Atopic Dermatitis
NCT00232076 ·Status: COMPLETED ·Phase: PHASE3
-
The Impact of Pediatric Skin Disorders: The "Big" Study
NCT03544866 ·Status: COMPLETED
-
Treatment of Chronic Itch in Atopic Dermatitis With Topical Naltrexone
NCT04154033 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study Of Atopic Dermatitis In Pediatrics
NCT00257569 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults
NCT01232985 ·Status: COMPLETED ·Phase: PHASE2
-
Wool Clothing for the Management of Childhood Atopic Dermatitis
NCT02534428 ·Status: COMPLETED ·Phase: NA
-
A Longitudinal Investigation of Skin Barrier Development From Birth and the Validation of Early Predictors of Atopic Eczema Risk: the Skin Testing for Atopic Eczema Risk (STAR) Study
NCT03143504 ·Status: UNKNOWN
-
Anti-relapse Efficacy and Tolerance Assessment of a Cosmetic Cream for Very Dry, Irritated to Atopic Sensitive Skin.
NCT05575882 ·Status: RECRUITING ·Phase: NA
-
HYPNOsis in the Management of Atopic Dermatitis in Children and Teenagers
NCT05611346 ·Status: RECRUITING ·Phase: NA
-
Topical Solution for the Treatment of Atopic Dermatitis
NCT02865356 ·Status: COMPLETED ·Phase: PHASE2